🇺🇸 Triticum Aestivum in United States
26 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 26
Most-reported reactions
- Cough — 5 reports (19.23%)
- Throat Irritation — 5 reports (19.23%)
- Abdominal Pain Upper — 2 reports (7.69%)
- Back Pain — 2 reports (7.69%)
- Dizziness — 2 reports (7.69%)
- Eye Pruritus — 2 reports (7.69%)
- Eyelid Oedema — 2 reports (7.69%)
- Nausea — 2 reports (7.69%)
- Pneumonia — 2 reports (7.69%)
- Pruritus — 2 reports (7.69%)
Frequently asked questions
Is Triticum Aestivum approved in United States?
Triticum Aestivum does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Triticum Aestivum in United States?
Coordinación de Investigación en Salud, Mexico is the originator. The local marketing authorisation holder may differ — check the official source linked above.